STOCK TITAN

The Carlyle Group Inc. 10-Q Filings

CG NASDAQ

Every 10-Q that The Carlyle Group Inc. (CG) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow CG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CG filings page.

Rhea-AI Summary

The Carlyle Group Inc. reported sharply weaker results for the six months ended June 30, 2026 despite steady fee revenue growth. Total revenues fell to $1,377.5 million from $2,546.0 million, driven mainly by a swing in investment income, as performance allocations moved from a gain to a loss.

Fund management fees increased to $1,241.0 million from $1,206.5 million and incentive fees rose, but total investment income turned to a loss of $502.8 million versus income of $853.8 million a year earlier. Net income attributable to Carlyle dropped to $4.9 million from $449.7 million, with diluted earnings per share declining to $0.01 from $1.23. Cash and cash equivalents were $1,256.5 million as of June 30, 2026, and total assets were $28,195.6 million, including significant consolidated fund assets and liabilities.

Rhea-AI Summary

The Carlyle Group Inc. reported a net loss for the quarter ended March 31, 2026, driven by negative investment performance allocations. Total revenues fell to $254.0 million from $973.1 million a year earlier, as performance allocations swung to a loss of $681.1 million from income of $222.9 million.

Fund management fees were relatively stable at $584.0 million versus $586.1 million, while incentive fees rose to $51.7 million from $43.2 million. Net loss attributable to Carlyle was $132.2 million, compared with net income of $130.0 million, resulting in diluted earnings per share of $(0.37) versus $0.35.

Total assets increased to $29,842.0 million from $29,116.0 million as of December 31, 2025, with cash and cash equivalents of $1,673.2 million. Shares of common stock outstanding were 359,974,427 as of May 5, 2026.

Rhea-AI Summary

The Carlyle Group Inc. reported sharply weaker results for the quarter ended September 30, 2025. Total revenues fell to $332.7 million from $2.64 billion a year earlier, driven by a swing in performance allocations from a $1.79 billion gain to a $606.7 million loss.

Net income dropped to $112.5 million from $615.7 million, and net income attributable to Carlyle fell to $0.9 million, with diluted earnings per share at $0.00 versus $1.63. Fee-based fund management fees still grew to $583.3 million from $532.7 million, partly offsetting volatile investment results.

Carlyle’s balance sheet showed total assets of $27.1 billion and total equity of $6.85 billion as of September 30, 2025. Operating cash flow was negative $2.08 billion for the nine months, but financing activities provided $3.02 billion, including $792.9 million of new 5.05% senior notes due 2035 and higher borrowings at consolidated funds.

Rhea-AI Summary

The Carlyle Group reported stronger results for the quarter ended June 30, 2025, with revenue and earnings rising sharply year-over-year. Total revenues for the quarter were $1,572.9 million versus $1,069.7 million a year earlier, led by higher fund management fees ($620.4M vs $534.4M) and a large increase in performance allocations ($638.8M vs $198.2M). Net income attributable to The Carlyle Group Inc. was $319.7 million for the quarter (total net income $328.1M), up from $148.2 million, and diluted EPS was $0.87 versus $0.40.

Balance sheet and cash flow highlights: total assets increased to $25,067.8 million from $23,103.5 million and total equity rose to $6,717.6 million. Investments including accrued performance allocations were $11,203.1 million, and investments of Consolidated Funds increased to $9,857.5 million. Accrued compensation and benefits remained elevated at $5,598.9 million. For the six months, operating activities used $520.9 million of cash while financing activities provided $526.8 million, reflecting dividends, share repurchases and non-controlling interest activity.